about
Preclinical assessment of carboplatin treatment efficacy in lung cancer by 18F-ICMT-11-positron emission tomographyDetection of tumor response to a vascular disrupting agent by hyperpolarized 13C magnetic resonance spectroscopy.Detecting treatment response in a model of human breast adenocarcinoma using hyperpolarised [1-13C]pyruvate and [1,4-13C2]fumarateA Systematic Comparison of 18F-C-SNAT to Established Radiotracer Imaging Agents for the Detection of Tumor Response to Treatment.Magnetic resonance imaging with hyperpolarized [1,4-(13)C2]fumarate allows detection of early renal acute tubular necrosisThe relationship between endogenous thymidine concentrations and [(18)F]FLT uptake in a range of preclinical tumour models.A comparison between radiolabeled fluorodeoxyglucose uptake and hyperpolarized (13)C-labeled pyruvate utilization as methods for detecting tumor response to treatmentProduction of hyperpolarized [1,4-13C2]malate from [1,4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors.Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma.Rapid Imaging of Tumor Cell Death In Vivo Using the C2A Domain of Synaptotagmin-I.AshwaMAX and Withaferin A inhibits gliomas in cellular and murine orthotopic modelsPreclinical evaluation of 3-18F-fluoro-2,2-dimethylpropionic acid as an imaging agent for tumor detection.Radiolabeled RGD tracer kinetics annotates differential αvβ 3 integrin expression linked to cell intrinsic and vessel expression.Evaluation of deuterated 18F- and 11C-labeled choline analogs for cancer detection by positron emission tomography.Kinetic modeling of hyperpolarized 13C label exchange between pyruvate and lactate in tumor cells.Magnetization transfer measurements of exchange between hyperpolarized [1-13C]pyruvate and [1-13C]lactate in a murine lymphoma.Correction to: The relationship between endogenous thymidine concentrations and [18F]FLT uptake in a range of preclinical tumour models.3'-Deoxy-3'-[(18)F]Fluorothymidine Uptake Is Related to Thymidine Phosphorylase Expression in Various Experimental Tumor Models.[18F]FSPG-PET reveals increased cystine/glutamate antiporter (xc-) activity in a mouse model of multiple sclerosis.Assessment of tumor redox status through (S)-4-(3-[18F]fluoropropyl)-L-glutamic acid positron emission tomography imaging of system xc- activityMapping Aldehyde Dehydrogenase 1A1 Activity using an [ F]Substrate-Based ApproachHigh-Throughput PET/CT Imaging Using a Multiple-Mouse Imaging SystemMeasurement of Tumor Antioxidant Capacity and Prediction of Chemotherapy Resistance in Preclinical Models of Ovarian Cancer by Positron Emission TomographyImaging Cancer Metabolism with Positron Emission Tomography (PET)Iron(II)/Persulfate Mediated Newman-Kwart Rearrangement[18F]-SuPAR: A Radiofluorinated Probe for Noninvasive Imaging of DNA Damage-Dependent Poly(ADP-ribose) Polymerase Activity
P50
Q28540769-9A44344B-A224-4AEC-A61D-2714A645455DQ33772430-97B913A9-4357-48E9-A666-58070D02B9E9Q34344210-668DC955-34C5-4F68-ABFD-A2808F94EF8DQ36021562-D683BFC7-D9AB-4453-9D94-4CC3B351037EQ36170731-7F53E675-F9FD-48C5-9ECF-35368FAEA08FQ37167105-5BE9CD3B-2519-4C76-B48B-6D8531505919Q37200476-E362AE5F-11E0-418E-A28E-E97E2F283240Q37446412-C9626A4A-C6C9-4C2F-BE6F-2A8ADAA5766DQ37603380-B3972A48-3CE5-42F2-8970-1E6FF7679F8FQ38716089-1BB44CE5-68B9-49B5-9153-A34B7C3AE3FFQ38813184-99A40510-9689-43E5-A04C-DAB7A646A507Q38976550-3F6052E2-0FC5-490F-89F3-F69EC3EEA486Q39047828-0A836647-3E59-4B5C-8F1E-B28001685C40Q39414054-B9FE395A-5C1B-4E9E-AA9B-0E98A8FD5E4EQ39539638-2310F829-80A0-4408-88B9-F5CA86D3887BQ43107467-BCC211BC-89C6-46D3-8E2F-926525213560Q47127952-E5011EEE-A62B-4089-97CF-E8B07FA2C3CBQ47877900-D8A0A281-7531-4A8F-B203-7CA6D0D76C79Q55174845-D24EBFF2-BE44-432C-9AC6-FBB912225CDBQ58605928-AD3A8A26-7F6C-4C72-9E9C-0FC87B1A08B6Q64251535-12BFDDBC-5DDB-42EF-8363-47588DFD8015Q90100208-7E1528CC-5DDD-4BB7-9F03-48717B2D9D19Q91079861-7A13BC56-2F38-4452-A215-74457793275AQ91375223-B5DA66B1-EED4-4615-B5CF-0645183EB9B6Q92084266-8CBD7B3D-E194-4DCC-9E27-576237BF5B43Q93024718-A5F1250E-F474-4EBA-9557-08EF6881F3AE
P50
description
researcher ORCID ID = 0000-0002-9475-2873
@en
name
Timothy Howard Witney
@ast
Timothy Howard Witney
@en
Timothy Howard Witney
@es
Timothy Howard Witney
@nl
type
label
Timothy Howard Witney
@ast
Timothy Howard Witney
@en
Timothy Howard Witney
@es
Timothy Howard Witney
@nl
prefLabel
Timothy Howard Witney
@ast
Timothy Howard Witney
@en
Timothy Howard Witney
@es
Timothy Howard Witney
@nl
P31
P496
0000-0002-9475-2873